Blog

Posted: 05 september 2026

New Migraine Prevention Guidelines Released

Updated migraine prevention guidance incorporates calcitonin gene-related peptide (CGRP)-targeted therapies and places greater emphasis on individualized treatment selection based on patient priorities. Preventive therapy should be offered to those with at least 4 migraine days per month, at least 4 moderate-to-severe headache days per…

Intensive blood pressure control cuts 7-year dementia risk by 15%, study finds

Past studies have linked cardiovascular disease to a higher risk of dementia — a group of neurological diseases, such as Alzheimer’s disease, that impact a person’s memory and thinking skills. Read more here.

What your gut microbes may have to do with how your brain ages

In a recent review published in the journal Frontiers in Molecular Neuroscience, researchers synthesized evidence on how diet-driven changes in the gut microbiota and microbial metabolites interact with immune and neurobiological pathways relevant to cognitive aging. Read more here.

A rising number of women have never been screened for cervical cancer. Here are the risks

Nearly 1 in 3 women ages 21 to 29 in 2023 had never received cervical cancer screening. This proportion was up from about 1 in 8 in 2005, according to a new study published August 27 in the journal JAMA Network…

ADHD and autism costs “out of control,” NHS leaders warn

Spending on attention deficit/hyperactivity disorder (ADHD) and autism services in England is “running out of control” with some areas seeing costs rise 10-fold in a year, NHS leaders have warned. The NHS Alliance—which represents NHS organisations in England, Wales, and…

Handheld Device Accurately Detects Cancer and HIV Without Lab

The VPodDuoss (the ‘V’ stands for virus)— can read and compare results from a variety of tests for pathogens or cancer-associated biomarkers. It’s the brainchild of Lee, University of Illinois Urbana-Champaign Computer Engineering Professor Brian Cunningham, PhD, and Bioengineering Professor Xing Wang, PhD,…

New study detects silent atherosclerosis in healthy young adults

Atherosclerosis, the process underlying most cardiovascular diseases, begins long before the first symptoms appear. An international study led by Professor Henning Bundgaard, Professor of Cardiology at Rigshospitalet in Copenhagen, Denmark, and Dr Borja Ibáñez, Scientific Director of the Centro Nacional…

Another Alzheimer’s blood test gets OK from FDA

The US Food and Drug Administration has cleared Roche and partner Eli Lilly’s blood test to help identify signs of Alzheimer’s disease in people age ‌55 and older with cognitive decline. The test, Elecsys pTau217, is a biomarker blood test…

World's first patient to undergo live AI-assisted brain surgery has tumour removed

The world's first patient to have brain surgery with live artificial intelligence assistance has successfully had his tumour removed. Rhys Hibbert, a father-of-two from Bedfordshire, could have lost his sight without the operation, said surgeons at University College London Hospital.…

Novel mRNA vaccine plus immunotherapy reduces melanoma relapse in phase 3 trial

In 2022, about 330,000 people around the world were diagnosed with the skin cancer melanoma, with about 60,000 people dying from the condition. On August 19, pharmaceutical companies Merck and Moderna announced the phase 3 clinical study results for an experimental therapy designed to help…

Telemedicine becomes more deeply embedded into hospital workflows

Health systems are using virtual nursing, tele-ICU, remote specialty care and EHR-integrated teams to extend scarce expertise, support bedside clinicians and redesign care delivery. Read more here.

FDA authorizes Avulux lenses for migraine-related light sensitivity

The U.S. Food and Drug Administration (FDA) has granted Avulux De Novo marketing authorization for its light-filtering lenses designed to decrease the impact of migraine-associated light sensitivity. The agency granted the company's request on Aug. 21. The authorization establishes a new FDA…

Get Involved

On the day